Clinical Trial Update: The Effect of Dupilumab on Lung Inflammation and Related Changes in Airway Volumes Detectable by Functional Respiratory Imaging in Patients With Moderate-severe Asthma [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating dupilumab's impact on lung inflammation and airway volumes in moderate-to-severe asthma using functional respiratory imaging; results h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• DUPIXENT (DUPILUMAB)

Snippet

Sponsor: Sanofi | Conditions: Asthma | Phase 4 | Status: COMPLETED | Results posted: 2024-07-10